Submissions

Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The submission has not been previously published, nor is it before another journal for consideration.
  • The manuscript is composed of a SINGLE Microsoft file
  • The submission manuscript file is typed as a single space, 12-point Times New Roman font, 1-inch margins in Microsoft Word. The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
  • The authors prepared a cover letter describing the significance of the manuscript and providing the names, institutional email, and institution names of a minimum of 4 potential reviewers, experts in the field. The authors guarantee that the reviewers suggested have no conflict of interest.
  • The corresponding author has obtained permission from all authors to submit this manuscript.
  • Authors declare that the content of the article is original and has not been plagiarized
  • Authors declare that figures have not been manipulated in anyway that would be considered unethical
  • All ethics approvals, protocols name and date of approval for human subjects, IRB and ICAUC have been included in the Materials and Methods
  • The manuscript includes an Author Contributions section following the CRediT taxonomy or similar format, detailing each author's role
  • All authors have disclosed any financial or non-financial conflicts of interest related to this work
  • A funding statement has been included, indicating sources of financial support or stating that no external funding was received
  • Authors have indicated whether their research involves Dual Use Research of Concern (DURC)

Author Guidelines

General File Requirements

  • Manuscripts must be submitted in English as a single Microsoft Word (.docx) file.
  • PDF is not an acceptable source file for submission or peer review.
  • Use 11-point Times New Roman font, single spacing, and 1-inch margins on all sides.
  • Format the manuscript as single-column text.
  • Avoid the use of tracked changes, comments, text boxes, floating text, or embedded objects.
  • All figures and tables must be embedded within the manuscript file, positioned after the first mention, and accompanied by appropriately formatted captions.
  • Figures must be resized to the final publication size before insertion and must be embedded at a resolution of 300 dpi in RGB color mode. CMYK mode is not accepted.
  • Captions must be in italicized 11-point Times New Roman font and placed directly below the figure or table.
  • The main manuscript file should ideally be under 10 MB.
  • Supplementary materials must be submitted separately as a single Word file, with each item clearly labeled (e.g., “Supplementary Figure S1”).
  • Authors must also upload individual high-resolution figures as TIFF files (≥300 dpi, RGB, minimum 3 inches wide) and tables as standalone Word files (not embedded as images).

File Naming Conventions

  • Main manuscript: [LastName]_Manuscript.docx
  • Supplementary figures: [LastName]_SuppFig1.tif
  • Supplementary tables: [LastName]_SuppTable1.docx
  • Cover letter: [LastName]_CoverLetter.docx

Title Page Requirements

  • Full manuscript title
  • Full author names (First Name, Middle Initial, Last Name)
  • ORCID iDs are strongly encouraged to support accurate indexing
  • Author affiliations using superscript numbers
  • Complete contact information for the corresponding author (email, institution, mailing address)

Abstract

  • Maximum of 250 words
  • Use a structured format (for research articles): Background, Methods, Results, Conclusions
  • Unstructured abstracts are acceptable for review articles
  • Do not include citations or abbreviations in the abstract

Keywords

  • Include 6 to 8 keywords, reflecting major concepts for indexing and discoverability

Main Sections

All original research articles should follow this structure:

  1. Introduction
  2. Materials and Methods
  3. Results
  4. Discussion

Figures and Tables

  • Embed all figures/tables after the first mention in the text
  • Label sequentially (e.g., Figure 1, Figure 2A–B, Table 1)
  • Each figure must have a descriptive title and caption, including:
  • Brief description
  • Explanation of statistical analysis, if applicable
  • Statement like: “Data are representative of X independent experiments.”
  • Figures: 300 dpi minimum, RGB color mode
  • Tables: Editable Word tables only; do not insert tables as images

References

  • Use Vancouver style, numbered sequentially
  • Example:
    [1] Smith J, Doe A. Title of article. *Journal Name*. 2023;12(3):123–130. https://doi.org/10.xxxx/yyyy
  • List all authors unless more than six, in which case use “et al.”
  • Include the full DOI as a clickable URL.
  • Submissions missing DOIs will be returned.

Funding Statement

Authors must disclose all sources of funding for the research or manuscript preparation. If no funding was received, state: “This research received no external funding.”

Author Contributions

Include a section specifying each author's role using the CRediT taxonomy.

Data Availability

Provide a Data Availability Statement in the manuscript:

  • Where the dataset(s) supporting the results can be accessed
  • If data are not publicly available, a justification must be provided

Ethical Compliance Statements

  1. Approval and Consent to Participate
  • For human studies: IRB/ethics committee approval, including protocol ID, date, and institution
  • For animal studies: IACUC or equivalent approval with reference number
  • Informed consent must be stated explicitly when applicable
  1. Competing Interests
  • Declare all financial and non-financial conflicts of interest, or state:

“The authors declare no conflicts of interest.”

  1. Consent for Publication

Include the following statement:

“We confirm that this manuscript is original, has not been previously published, and is not under review elsewhere. All authors consent to its publication and agree to the journal’s terms and open access policy (CC BY 4.0).”

Research Integrity and Special Considerations

  • Authors must indicate whether their research involves Dual Use Research of Concern (DURC)
  • Authors must confirm compliance with sex and gender reporting guidelines, if applicable
  • Authors must declare that images have not been inappropriately manipulated or misrepresented
  • If applicable, include clinical trial registration numbers and registry details

Supplementary Material

  • Refer to supplementary items in the text (e.g., “Supplementary Figure S1”)
  • Submit all supplementary files as separate files, clearly named
  • Use acceptable formats: .docx for tables, .tif/.jpg/.png for figures (300 dpi minimum)

Last updated: August 2025

 

Articles

Research article 

Research Articles are original, peer-reviewed contributions that present significant advances in cancer biology, tumor microenvironment, immunotherapy, or targeted therapeutic strategies. Articles must offer new data, insights, or interpretations supported by rigorous experimental or computational methodology. 

  • Word Limit: The main text (Introduction, Methods, Results, and Discussion) must not exceed 5,000 words, not including References.
  • Figures and Tables: A combined maximum of 8 figures and/or tables is allowed. Additional data or complex visualizations may be included as supplementary material. Embed figures and tables in the body of the text after the first mention. Clearly labeled in sequence: e.g., Figure 1, Figure 2A–B. For each figure, include a clear title and a legend caption. The caption should appear immediately below the figure in the Word document. Acceptable formats: high-resolution (≥300 dpi) images, tables only in Word (not images).
  • Abstract: Structured abstracts should be limited to 250 words and divided into labeled sections that summarize key parts of the manuscript. Common section headings include Background, Methods, Results, and Discussion (Conclusions).
  • Keywords: Authors are required to provide 6-8 keywords. Keywords should be written in English and avoid using keywords that consist of multiple words. 
  • Material and methods: The section should provide sufficient detail to allow others to replicate the findings, while avoiding unnecessary elaboration on standard procedures. Commonly used techniques (e.g., Western blotting, cloning, qPCR, flow cytometry, immunofluorescence) should be referenced by name only, without detailed step-by-step protocols, unless a novel modification has been introduced. Authors must provide sufficient detail to ensure reproducibility, including but not limited to primer sequences, antibody catalog numbers and vendors for all immunodetection procedures, cell line names and their source (including the original repository or supplier and authentication status), and plasmid vectors or constructs with source information (e.g., Addgene ID, originating lab, or commercial provider). Authors must also include details of experimental controls, the number of biological replicates, statistical methods, and software versions used in data analysis. 

The Materials and Methods section may contain standardized descriptions of widely used techniques and protocols. As such, this section is not subject to plagiarism in the conventional sense, provided the text accurately and appropriately describes established methods. Authors may reuse standard formulations for methodological descriptions when necessary for clarity and must properly cite sources. Any customized or novel modifications to methods must be identified and described in the authors' own words.

  • References: The number of references cited in a research manuscript must be limited to a maximum of 50. Authors are expected to cite only the most relevant, high-quality, and recent publications directly supporting the study’s rationale, methodology, findings, and interpretation.
  • Supplementary Material: Extended data, additional figures, detailed methods, and raw datasets may be submitted as supplementary files, which will be reviewed alongside the main manuscript.

Review

Review article

Review articles generally fall into two categories: descriptive/comprehensive and critical. 

Critical reviews: These articles rigorously evaluate key advances, identifying gaps in knowledge and highlighting emerging trends and challenges. They provide analysis of future research directions and contribute to guiding the evolution of the field. Critical reviews are generally more focused and more concise than descriptive/comprehensive reviews. This type of review demands a high level of insight, expertise, and knowledge and should be authored by recognized experts in the field. Critical reviews are often commissioned by the editors.

Comprehensive review: The main purpose is to summarize and organize existing published literature on a broad topic, providing readers with a comprehensive overview without extensive personal analysis or interpretation. These reviews serve as valuable reference tools for researchers, clinicians, or trainees who are new to a particular field. 

  • Word Limit: The main text (Introduction, Methods, Results, and Discussion) must not exceed 10,000 words, not including References. The introduction should start with a paragraph on Historical Context (Discovery and Evolution of the Field).
  • Figures and Tables: A combined minimum of 4 and maximum of 6 figures and/or tables is allowed. Authors of non-research articles, such as reviews, can include figures and tables that have been previously published in other journals, provided they confirm on submission that permission has been obtained from the original publisher (if applicable) and cite the original article. 
  • Abstract: Abstracts should be unstructured, limited to 250 words, and written as a single paragraph with no subheadings.
  • Keywords: Authors are required to provide 6-8 keywords. Keywords should be written in English and avoid keywords consisting of multiple words.
  • References: Authors submitting review articles are encouraged to choose broad topics, providing an in-depth synthesis of current knowledge in the field. To ensure a thorough and up-to-date perspective, a minimum of 150+ references should be included, emphasizing recent publications that reflect the latest scientific developments. 

Commentary

Commentary

Commentaries are short, invited-only articles that provide an expert perspective on a recently published study in the Cancer Biome and Targeted Therapy journal. These are typically reserved for one of the peer reviewers, selected by the editors based on their subject expertise and ability to contextualize the work within the broader field. The invitation to write a commentary is extended only after the peer review process has concluded and a final decision has been made on the manuscript. This ensures that the integrity and confidentiality of the peer review process are fully maintained. Reviewers invited to write a commentary must disclose any potential conflicts of interest and must not reveal their role in the peer review process within the published article. 

  • Authors: Commentaries have a limit of three authors.
  • Word Limit: Text must not exceed 800 words. There is no abstract and no subheadings.
  • Figures and Tables: A maximum of one figure or one table is allowed.
  • References: A maximum of five references.

Brief Reports

Reports

Reports are concise articles that communicate focused experimental findings or novel observations of high interest to the field. These reports are intended for data sets that are limited in scope but scientifically and clinically relevant. Examples include, but are not limited to, the identification of novel biomarkers for disease diagnosis, prognosis, or therapeutic response; the discovery of new genetic or epigenetic alterations; the development of innovative assays or experimental techniques; early preclinical findings from emerging therapeutic agents; unexpected mechanistic insights from small-scale studies; or validation of key biological targets using limited but robust data sets.

  • Word Limit: The main text (Introduction, Methods, Results, and Discussion) must not exceed 2,000 words, not including References.
  • Figures and Tables: A combined maximum of 4 figures and/or tables is allowed. Additional data or complex visualizations may be included as supplementary material. Embed figures and tables in the body of the text after the first mention. Clearly labeled in sequence: e.g., Figure 1, Figure 2A–B. For each figure, include a clear title and a legend caption. The caption should appear immediately below the figure in the Word document. Acceptable formats: high-resolution (≥300 dpi) images, tables only in Word (not images).
  • Abstract: Structured abstracts should be limited to 250 words and divided into labeled sections that summarize key parts of the manuscript. Common section headings include Background, Methods, Results, and Discussion.
  • Keywords: Authors are required to provide 6-8 keywords. Keywords should be written in English and avoid keywords consisting of multiple words. 
  • Material and methods: The section should provide sufficient detail to allow others to replicate the findings, while avoiding unnecessary elaboration on standard procedures. 
  • References: The number of references cited in a research manuscript must be limited to a maximum of 30. 
  • Supplemental files are not admitted.

Privacy Statement

Privacy Policy

Cancer Biome and Targeted Therapy is committed to protecting the privacy of our authors, reviewers, readers, and visitors. This Privacy Policy outlines how we collect, use, and safeguard personal information through our journal website and submission system. We do not sell or share personal information with third parties for commercial purposes. We comply with applicable data protection regulations, including the General Data Protection Regulation (GDPR), UK-GDPR, and the California Consumer Privacy Act (CCPA/CPRA). By using this website, you acknowledge and agree that your personal data may be processed following these regulations. Any legal disputes or claims arising out of or relating to this Privacy Policy shall be governed by and construed following the laws of the United States, and subject to the exclusive jurisdiction of the courts of the United States.

Types of Cookies We Use:

  • Essential cookies: Necessary for the website to function properly (e.g., login sessions, security).
  • Analytics cookies: Help us understand how visitors interact with the site to improve performance.
  • Functional cookies: Enable enhanced features such as saving your cookie preferences.

Information We Collect

We may collect the following types of personal data:

  • Name, affiliation, and contact details (e.g., email address)
  • ORCID ID or other identifiers
  • Manuscript metadata and authorship information
  • Peer review comments and related correspondence
  • Usage data through cookies (e.g., IP address, browser type)

How We Use the Information

Collected data is used for:

  • Editorial and peer review processes
  • Author and reviewer communications
  • Website analytics and user experience improvements
  • Compliance with indexing and archiving requirements

Data Retention

We retain personal data as long as necessary to support the scholarly record, comply with legal obligations, and ensure archival integrity.

Your Choices:

  • You can accept or decline non-essential cookies via the cookie consent banner.
  • Your choice will be remembered for the duration of your browser session.
  • Disabling cookies may affect some functionalities of the site, but will not prevent access to core content.

Third-Party Services

Our site may include links to external platforms (e.g., ORCID, Crossref, PubMed Central, Google Scholar). We are not responsible for the privacy practices of these sites.

Your Rights

Users may request access to, correction of, or deletion of their data by contacting the editorial office. For questions regarding this Privacy Policy, please email: submissions@cancerbiometherapy.com

Last updated: August 2025